EMG
OSIR

Ellington Management Group’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Ellington Management Group’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-13,700
Closed -$241K – 1068
2015
Q1 		$241K Buy
+13,700
New +$230K 0.05% 538
2014
Q4 		– Sell
-15,700
Closed -$198K – 707
2014
Q3 		$198K Buy
+15,700
New +$224K 0.14% 233

Other funds holding OSIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VCM
Venator Capital Management Toronto, Ontario, Canada $48.7M AUM 87.97% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Ellington Management Group's OSIR Position: Q2 2015 in Review

Ellington Management Group sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2015, closing a stake of 13,700 shares — an estimated $241K sold.

Ellington Management Group first reported a position in OSIR in Q3 2014 and held it in 2 quarters. The position peaked at $241K in Q1 2015. 87 funds tracked by Wall St. Rank hold OSIR as of Q2 2015.

  • Ellington Management Group reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2015 after selling out during the quarter.
  • Ellington Management Group sold 13,700 Osiris Therapeutics, Inc. Common Stock shares in Q2 2015, an estimated $241K.
  • Ellington Management Group first reported a position in Osiris Therapeutics, Inc. Common Stock in Q3 2014 and held it in 2 quarters.
  • Ellington Management Group's Osiris Therapeutics, Inc. Common Stock position peaked at $241K in Q1 2015.
  • 87 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2015.

Based on Ellington Management Group's 13F filing for Q2 2015, filed 14 Aug 2015.